Moreover, we investigated whether FOXC1 binds to the same regions in patient samples, and the results revealed that compared to healthy controls, FOXC1 binding sites in the HCC samples were indeed enriched in these regions. This evidence concerns the gene FOXC1 and hepatocellular carcinoma.